These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7235674)

  • 21. A multicentre study of the susceptibility of a variety of bacteria to cephalothin, cefamandole, tobramycin and gentamicin.
    du T Naudé W; van den Ende J; Botha P; Forder A; Hyland J; de Klerk HC; Neiteler BF; Koornhof HJ; Robinson R; Robins-Browne R; Block C; Appelbaum PC; Africa CW; van Rensburg AJ; Jooste PJ; Crewe-Browne H; Fernandez A
    S Afr Med J; 1977 Nov; 52(20):798-800. PubMed ID: 305120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Ravagnan G
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1644-7. PubMed ID: 3435110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. O serotyping of Providencia stuartii isolates collected from twelve hospitals.
    Penner JL; Hinton NA; Duncan IB; Hennessy JN; Whiteley GR
    J Clin Microbiol; 1979 Jan; 9(1):11-4. PubMed ID: 429535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of the combined use of tobramycin with carbenicillin or cephalosporins in experimental infection in mice caused by Providencia stuartii].
    Shapovalova SP; Malkova IV; Iakushkina IV
    Antibiotiki; 1982 Feb; 27(2):130-3. PubMed ID: 7065647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL; Lewis RP; Meyer RD
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of O-serotyping in a study of Providencia rettgeri (Proteus rettgeri) isolated from human and nonhuman sources.
    Penner JL; Hennessy JN
    J Clin Microbiol; 1979 Dec; 10(6):834-40. PubMed ID: 521481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Providencia stuartii: a review of a multiply antibiotic-resistant bacterium.
    Hawkey PM
    J Antimicrob Chemother; 1984 Mar; 13(3):209-26. PubMed ID: 6373713
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection.
    Jones BD; Mobley HL
    Infect Immun; 1987 Sep; 55(9):2198-203. PubMed ID: 3623698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in urease activity of endemic hospital strains of Proteus rettgeri and Providencia stuartii.
    Penner JL; Hinton NA; Whiteley GR; Hennessy JN
    J Infect Dis; 1976 Oct; 134(4):370-6. PubMed ID: 789790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F; Flournoy DJ; Qadri SM
    Chemotherapy; 1983; 29(1):37-42. PubMed ID: 6219865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive accuracy of disk diffusion test for Proteus vulgaris and Providencia species against five newer orally administered cephalosporins, cefdinir, cefetamet, cefprozil, cefuroxime, and loracarbef.
    Biedenbach DJ; Jones RN
    J Clin Microbiol; 1994 Feb; 32(2):559-62. PubMed ID: 8150976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Commercial identification systems often fail to identify Providencia stuartii.
    Cornaglia G; Dainelli B; Berlutti F; Thaller MC
    J Clin Microbiol; 1988 Feb; 26(2):323-7. PubMed ID: 3277997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasion of HEp-2 and other eukaryotic cell lines by Providenciae: further evidence supporting the role of Providencia alcalifaciens in bacterial gastroenteritis.
    Janda JM; Abbott SL; Woodward D; Khashe S
    Curr Microbiol; 1998 Sep; 37(3):159-65. PubMed ID: 9688814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of the genera Proteus, Morganella, and Providencia by ribotyping.
    Pignato S; Giammanco GM; Grimont F; Grimont PA; Giammanco G
    J Clin Microbiol; 1999 Sep; 37(9):2840-7. PubMed ID: 10449462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibilities of gentamicin-resistant Gram-negative aerobic bacilli to cefotetan and other beta-lactams.
    Hart CA; Percival A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():95-101. PubMed ID: 6573329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inducible expression of an aminoglycoside-acetylating enzyme in Providencia stuartii.
    Swiatlo E; Kocka FE
    J Antimicrob Chemother; 1987 Jan; 19(1):27-30. PubMed ID: 3549668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibilities of 45 clinical isolates of Proteus penneri.
    Fuksa M; Krajden S; Lee A
    Antimicrob Agents Chemother; 1984 Sep; 26(3):419-20. PubMed ID: 6508270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. O-serotyping Providencia alcalifaciens.
    Penner JL; Fleming PC; Whiteley GR; Hennessy JN
    J Clin Microbiol; 1979 Dec; 10(6):761-5. PubMed ID: 521478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance of Providencia stuartii to chlorhexidine: a consideration of the role of the inner membrane.
    Ismaeel N; el-Moug T; Furr JR; Russell AD
    J Appl Bacteriol; 1986 Apr; 60(4):361-7. PubMed ID: 3087933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.